Interestingly, lncRNA regulator of reprogramming (linc-ROR) has been associated with multidrug resistance in breast cancer such that up-regulated linc-ROR contributed to chemotherapy tolerance and invasion of breast cancer cells [2]. This evidence concerns the gene LINC-ROR and breast carcinoma.